Publications by authors named "Mark Boye"

Claim this Profile
K
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.
Rebecca Ellen Goulding, Matthew Chenoweth, Gebra Cuyun Carter, Mark Ernest Boye, Kristin M Sheffield

Cancer Treat Res Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France.
Kaisa Taipale, Katherine B Winfree, Mark Boye, Mickael Basson, Ghassan Sleilaty

Clinicoecon Outcomes Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials.
Danjie Zhang, Ming-Hui Chen, Joseph G Ibrahim, Mark E Boye, Wei Shen

J Comput Graph Stat· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JMFit: A SAS Macro for Joint Models of Longitudinal and Survival Data.
Danjie Zhang, Ming-Hui Chen, Joseph G Ibrahim, Mark E Boye, Wei Shen

J Stat Softw· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial.
Mark Boye, Xin Wang, Vichien Srimuninnimit, Jin Hyoung Kang, Chun-Ming Tsai

Clin Lung Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can bundled payment improve quality and efficiency of care for patients with hip fractures?
Evgeniya Antonova, Mark E Boye, Namrata Sen, Amy K O'Sullivan, Russel Burge

J Aging Soc Policy· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.
Gayathri Kumar, Beth Woods, Lisa M Hess, Joseph Treat, Mark E Boye

Lung Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.
A Lawrence Gould, Mark Ernest Boye, Michael J Crowther, Joseph G Ibrahim, George Quartey

Stat Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to discussants of 'Joint modeling of survival and longitudinal non-survival data: current methods and issues. report of the DIA Bayesian joint modeling working group'.
A Lawrence Gould, Mark Ernest Boye, Michael J Crowther, Joseph G Ibrahim, George Quartey

Stat Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.
Danjie Zhang, Ming-Hui Chen, Joseph G Ibrahim, Mark E Boye, Ping Wang

Stat Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Jason Yeaw, Shawn Halinan, Dionne Hines, Amy Delozier, Magaly Perez, Mark Boye, Kristina Secnik Boye

Appl Health Econ Health Policy· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint modeling of longitudinal outcomes and survival using latent growth modeling approach in a mesothelioma trial.
Ping Wang, Wei Shen, Mark Ernest Boye

Health Serv Outcomes Res Methodol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.
Talia S Foster, Jeffrey D Miller, Mark E Boye, Marissa B Blieden, Risha Gidwani

Cancer Treat Rev· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint modeling of multiple longitudinal patient-reported outcomes and survival.
Laura A Hatfield, Mark E Boye, Bradley P Carlin

J Biopharm Stat· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.
Christiane Querfeld, Timothy M Kuzel, Youn H Kim, Pierluigi Porcu, Madeleine Duvic, Mark Boye

Leuk Lymphoma· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of follicular non-Hodgkin's lymphoma.
Talia Foster, Jeffrey D Miller, Mark E Boye, Mason W Russell

Pharmacoeconomics· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of 24-h recall ratings of pain severity: biasing effects of "Peak" and "End" pain.
Mark P Jensen, Jack Mardekian, Mani Lakshminarayanan, Mark E Boye

Pain· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical visits among adults with symptoms commonly associated with an overactive bladder.
Sunny H Kim, Mark Boye, Samir K Bhattacharyya, Karin Coyne, Ravinder Dhawan

BJU Int· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery.
Nancy A Nussmeier, Andrew A Whelton, Mark T Brown, Girish P Joshi, Richard M Langford, Mark E Boye

Anesthesiology· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis